Lumexa Imaging Holdings Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Lumexa Imaging Holdings Inc 's ROA in the third quarter of 2026?
Lumexa Imaging Holdings Inc achieved a return on average assets (ROA) of 0.46 % in its third quarter of 2026, this is above LMRI's average return on assets of 0%.
Lumexa Imaging Holdings Inc assets over the 12 months ending in its third quarter of 2026 are valued at $1,757 million

ROA has improved compared to -0.47% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector Lumexa Imaging Holdings Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the second quarter of 2026 at no. .

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	-	-	-	-	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	8	-6	-17	-18	-15
Return On Assets (TTM)	0.46 %	-0.47 %	-1.89 %	-4.17 %	-
LMRI's Total Ranking	#	#	#	#	#
Total Assets (TTM) in million	1,693	1,809	1,763	1,765	0
Seq. Total Assets Change	-6.41 %	2.58 %	-0.07 %	-	-
Seq. Net Income Change	161.49 %	59.87 %	-	-	-

LMRI's 5 Years Annual ROA >> Back to LMRI Management Effectiveness >> Compare LMRI ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Assets Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Lumexa Imaging Holdings Inc 's Assets	$ 1,693 million	LMRI's Balance sheet
Lumexa Imaging Holdings Inc 's Income	$ 7 million	Quarterly LMRI's Income Statement
LMRI's Income by Division		See LMRI's Income by Division

Annual Return On Assets	FY	FY	FY	FY	FY
Y / Y Total Assets Change	-	-	-	-	-
Total Assets in million	0	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	0	0	0	0	0
Annual Return On Assets	-	-	-	-	-

LMRI's 5 Years Annual ROA >> Back to LMRI Management Effectiveness >> Compare LMRI ROA to its Competitors

More Return On Assets Ratios
LMRI's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LMRI's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for LMRI's Competitors
Subscribers only: Roa for Lumexa Imaging Holdings Inc 's Suppliers
Subscribers only: Return On Assets for LMRI's Customers

You may also want to know
LMRI's Roi	LMRI's Inventory Turnover Ratio	LMRI's Growth Rates	LMRI's Dividend Comparisons
	LMRI's Profitability Ratios	LMRI's Asset Turnover Ratio	LMRI's Dividend Growth
LMRI's Roe	LMRI's Valuation Ratios	LMRI's Financial Strength Ratios	LMRI's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Teva Pharmaceutical Industries Limited	1.26 %
Community Health Systems Inc	1.21 %
Biogen Inc	1.13 %
Waters Corporation	0.50 %
Integra Lifesciences Holdings Corp	0.37 %

Date modified: 2026-11-13T08:45:20+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.